Apotex Fiscal Q2 Adjusted Earnings Drop YoY

07:19 AM EST, 11/12/2026 (MT Newswires) -- Apotex Health (APTX.TO) posted adjusted earnings of CA$0.57 per diluted share in its fiscal second quarter from CA$0.61 in prior year. Analysts expected CA$0.37. Revenue for the quarter ended Sept. 30 was CA$852.9 million, compared to CA$843.5 million in the year-ago period. Analysts expected CA$828.3 million. Apotex raised its fiscal 2027 guidance including revenue growth of 9%-10%, compared to the initial estimate of 7%-8%, citing its strong operational performance in the first half and an expected acceleration of revenue growth in the second half.